Maria Grunwald

Maria Grunwald is a highly experienced professional with over 15 years of expertise in business development and operations within various company stages.

She has an impressive track record of negotiating over 60 licensing and collaboration agreements in the biotechnology and pharmaceutical sectors.

With background in biologics and small molecules, Maria has played crucial roles as a joint steering committee member for numerous discovery and development alliances.

Maria holds a Ph.D. achieved with magna cum laude from Johns Hopkins University and University of Cologne, along with an MBA from MIT Sloan.

Her specialties include negotiation of various agreements, deal guidance, corporate strategy, new business development, partner identification, market assessments, and alliance management.

Maria's educational background includes studies in MBA with a focus on Entrepreneurship, Finance, and Strategy from MIT Sloan, a Ph.D./Dr. rer. nat in Neuroscience from Johns Hopkins University and University of Cologne, and B.S./M.S. in Biochemistry from University of Hannover/Medizinische Hochschule Hannover.

Throughout her career, Maria has held key positions such as Business Development Executive at Kernal Bio, Director of Business Development at Radius, Business Development Consultant at Predictive Biosciences, Associate Director of Business Development at Dyax Corp., among others.

She has also contributed as an Intern in Business Development at IRL Biopharm, Team Member in New Enterprises at MIT Entrepreneurship Center, and Research Fellow at Massachusetts General Hospital/Harvard Medical School.